Back to 
BlackRock, Inc.
BlackRock, Inc.
MYGN7 quarters
Position history for BlackRock, Inc.'s holdings in MYRIAD GENETICS INC
BlackRock, Inc. holds 10.9M shares of MYGN (MYRIAD GENETICS INC), worth $62.2M as of 2026-Q2. The position was increased (+22.5% shares). MYGN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$62.2M
Current Shares
10.9M
Total Value Change
-$155.9M
Total Shares Change
-5M
Quarter-by-Quarter History
Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC